Welcome to 2024

The Future of Hemostasis Management: Exploring the Clinical Benefits of ClotPro TPA-Test

Concentration–effect relationship for tranexamic acid inhibition of tissue plasminogen activator-induced fibrinolysis in vitro using the viscoelastic ClotPro® TPA-test

The effect of t-PA on fibrinolytic resistance in a patient with portal vein thrombosis

Fibrinolysis resistance in the critically ill

Trial of intravenous nafamostat mesylate in COVID pneumonitis:

Coagulation Monitoring in ECMO

Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro®

Perioperative Coagulation Monitoring

Greater Fibrinolysis Resistance but No Greater Platelet Aggregation in COVID Patients

The most advanced device on the market